Yes. Breast reconstruction as well as the follow-up balancing procedures are usually covered by Medisave/Medishield/private insurance plans. The aim of breast reconstruction is to restore the patient’s appearance back to normal.
With adequate clinical and radiological follow up, breast reconstruction does not interfere with breast cancer surveillance.
If bilateral mastectomies are being performed, both breasts can be reconstructed at the same time, either with implants or the patient’s own tissue. The surgical time, as expected, will be longer.
BIA-ALCL is a rare lymphoma that is associated with breast implants, mostly occurring in patients who have undergone textured-surface breast implants. Since 1997, there have been over 300 cases reported. As this is an uncommon disease, data is still being accumulated and medical knowledge on this topic continues to evolve.
The most common presentation is a late effusion, with breast enlargement more than one year following the breast implant surgery. Other less common symptoms include a breast mass, enlargement of the lymph nodes of the axilla, or fever and night sweats. The average time to onset of BIA-ALCL after implantation is 10 years. BIA-ALCL may affect patients with either silicone- or saline-filled implants.
BIA-ALCL is diagnosed radiologically together fluid aspiration which is sent for testing. If confirmed, further investigations may be required. BIA-ALCL usually presents early, and curative treatment can be performed by implant removal and complete excision of the peri-implant capsule. Unless spread is found, no other treatments are usually needed.
If you already have breast implants, there is no need to change your routine medical care and follow-up. Should you experience any of the symptoms described above, do arrange for a consultation with your plastic surgeon.